PubRank

J Van Cutsem

Author PubWeight™ 57.67‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Mucormycosis during deferoxamine therapy is a siderophore-mediated infection. In vitro and in vivo animal studies. J Clin Invest 1993 2.45
2 The preparation and antimycotic properties of derivatives of 1-phenethylimidazole. J Med Chem 1969 2.28
3 The clinical pharmacokinetics of itraconazole: an overview. Mycoses 1989 2.27
4 Ketoconazole -- a new broad spectrum orally active antimycotic. Experientia 1979 2.24
5 Azole resistance in Candida albicans. J Med Vet Mycol 1986 2.17
6 Treatment of vaginal candidiasis with ketoconazole, a new, orally active, antimycotic. Eur J Obstet Gynecol Reprod Biol 1979 2.01
7 Itraconazole, a new triazole that is orally active in aspergillosis. Antimicrob Agents Chemother 1984 1.83
8 Antimycotic imidazoles. part 4. Synthesis and antifungal activity of ketoconazole, a new potent orally active broad-spectrum antifungal agent. J Med Chem 1979 1.78
9 The influence of gastric acidity on the bio-availability of ketoconazole. J Antimicrob Chemother 1980 1.68
10 Activity of orally, topically, and parenterally administered itraconazole in the treatment of superficial and deep mycoses: animal models. Rev Infect Dis 1987 1.64
11 Deferoxamine augments growth and pathogenicity of Rhizopus, while hydroxypyridinone chelators have no effect. Kidney Int 1994 1.55
12 Promotion of pseudomycelium formation of Candida albicans in culture: a morphological study of the effects of miconazole and ketoconazole. Postgrad Med J 1979 1.47
13 Antimycotic azoles. 7. Synthesis and antifungal properties of a series of novel triazol-3-ones. J Med Chem 1984 1.27
14 Itraconazole in the treatment of chromoblastomycosis due to Fonsecaea pedrosoi. Int J Dermatol 1992 1.20
15 Ketoconazole in experimental candidosis. Rev Infect Dis 1981 1.19
16 The pharmacokinetics of ketoconazole in severely immunocompromised patients. J Antimicrob Chemother 1982 1.17
17 The antifungal activity of ketoconazole. Am J Med 1983 1.15
18 Immunohistochemical identification of Penicillium marneffei by monoclonal antibody. Int J Dermatol 1992 1.09
19 Itraconazole versus griseofulvin in the treatment of tinea capitis: a double-blind randomized study in children. Int J Dermatol 1994 1.07
20 Antimycotic azoles. 6. Synthesis and antifungal properties of terconazole, a novel triazole ketal. J Med Chem 1983 1.07
21 The interaction of miconazole and ketoconazole with lipids. Biochem Pharmacol 1982 1.06
22 The activity of ketoconazole in clinical isolates of candida albicans cultured in a mycelium promoting medium. Mykosen 1981 1.01
23 Experimental systemic dermatophytosis. J Invest Dermatol 1984 1.01
24 Posttreatment itraconazole levels in the nail. New implications for treatment in onychomycosis. J Am Acad Dermatol 1992 1.00
25 Culture media for the study of the effects of azole derivatives on germ tube formation and hyphal growth of C. albicans. Mykosen 1986 0.98
26 Oral treatment with ketoconazole in systemic candidosis of guinea-pigs: microbiology, hematology and histopathology. Sabouraudia 1985 0.91
27 Experimental cutaneous Candida albicans infection in guinea-pigs. Sabouraudia 1971 0.89
28 The in-vitro antifungal spectrum of itraconazole. Mycoses 1989 0.87
29 Experimental zygomycosis due to Rhizopus spp. infection by various routes in guinea-pigs, rats and mice. Mycoses 1988 0.86
30 Structural degeneration of Aspergillus fumigatus after exposure to saperconazole. J Med Vet Mycol 1989 0.84
31 Role of animal and human pharmacology in antifungal drug design. Ann N Y Acad Sci 1988 0.84
32 Therapeutic efficacy of itraconazole in systemic candidosis in guinea pigs. Chemotherapy 1987 0.83
33 Terconazole - a new broad-spectrum antifungal. Chemotherapy 1983 0.82
34 Antifungal activity of enilconazole on experimental Aspergillosis in chickens. Avian Dis 1983 0.81
35 In vitro activity of enilconazole against Aspergillus spp. and its fungicidal efficacy in a smoke generator against Aspergillus fumigatus. Mycoses 1988 0.81
36 Treatment of vaginal candidosis with oral ketoconazole. Eur J Obstet Gynecol Reprod Biol 1983 0.80
37 Experimental cryptococcosis: dissemination of Cryptococcus neoformans and dermotropism in guinea-pigs. Mykosen 1986 0.80
38 Anticandidal activities of terconazole, a broad-spectrum antimycotic. Antimicrob Agents Chemother 1986 0.80
39 Oral itraconazole versus topical bifonazole treatment in experimental dermatophytosis. Mycoses 1993 0.80
40 Histopathology of experimental systemic candidosis in guinea-pigs. Sabouraudia 1984 0.80
41 The activity of ketoconazole and itraconazole against Aspergillus fumigatus in mixed cultures with macrophages or leukocytes. Mykosen 1986 0.79
42 Vapour phase activity of imazalil. Chemotherapy 1981 0.78
43 Treatment of candidal vaginitis with miconazole, a new broad-spectrum antimycotic. Changes in microbiology, vaginal pH and cytology. Arzneimittelforschung 1973 0.78
44 Animal models for dermatomycotic infections. Curr Top Med Mycol 1989 0.78
45 Onychomycosis caused by Microsporum canis: treatment with itraconazole. J Am Acad Dermatol 1995 0.77
46 Bilogical and toxicological properties of econazole, a broad-spectrum antimycotic. Arzneimittelforschung 1975 0.76
47 Imaging of systemic Candida albicans infections with a radioiodinated monoclonal antibody: experimental study in the guinea pig. Int J Rad Appl Instrum B 1991 0.76
48 Primary cutaneous cryptococcosis. Dermatologica 1985 0.76
49 Immunomodulation and antifungal therapy of experimental invasive candidosis, histoplasmosis and aspergillosis: recent advances and concepts. J Med Vet Mycol 1992 0.76
50 Experimental aspergillosis in guinea pigs: influence of itraconazole on fungaemia and invasive fungal growth. Mycoses 1995 0.75
51 Ketoconazole 2% emulsion in the treatment of seborrheic dermatitis. Int J Dermatol 1991 0.75
52 [Determination of ketoconazole in hair from orally treated rats and guinea pigs (author's transl)]. Mykosen 1980 0.75
53 A three-stage clinical evaluation of etonam (R 10 100) in the treatment of chronic athlete's foot. Dermatologica 1969 0.75
54 The influence of antibiotics on the growth of Candida albicans in the vagina: an experiment with vaginal fluid. Eur J Obstet Gynecol Reprod Biol 1985 0.75
55 Effects of ketoconazole and itraconazole on growth and sterol synthesis in Pityrosporum ovale. J Med Vet Mycol 1986 0.75
56 Antimycotic imidazoles. 5. Synthesis and antimycotic properties of 1-[[2-aryl-4-(arylalkyl)-1,3-dioxolan-2-yl]methyl]-1H-imidazoles. J Med Chem 1981 0.75
57 Itraconazole in the treatment of superficial mycoses--a double-blind study vs. placebo. Clin Exp Dermatol 1990 0.75
58 Sensitivity of Moraxella bovis in vitro to miconazole nitrate. Vet Rec 1983 0.75
59 Double-blind comparison of itraconazole with griseofulvin in the treatment of tinea pedis and tinea manuum. Mycoses 1988 0.75
60 [Oral long-term treatment of onychomycoses with ketoconazole (author's transl)]. Mykosen 1980 0.75
61 Experimental study of a new fungistatic agent: R 10100 1-(1,2,3,4-tetrahydro-1-naphthyl)-5-(ethoxycarbonyl)-imidazole nitrate. Chemotherapy 1967 0.75
62 The biological and toxicological properties of imazalil. Arzneimittelforschung 1981 0.75
63 Fungal infections in birds in captivity--six case reports. Mykosen 1987 0.75
64 The growth-promoting activity of vaginal fluid for Candida albicans (and the problem of enhanced susceptibility to vaginal candidosis). Eur J Obstet Gynecol Reprod Biol 1985 0.75
65 Treatment with enilconazole spray of dermatophytosis in rabbit farms. Mykosen 1985 0.75
66 Oral, topical and parenteral antifungal treatment with itraconazole in normal and in immunocompromised animals. Mycoses 1989 0.75
67 Phase II trial: an evaluation of oral saperconazole in acute vaginal candidosis: a comparison of three dosage schedules. Eur J Obstet Gynecol Reprod Biol 1991 0.75
68 Miconazole treatment of pityriasis versicolor a review. Mykosen 1978 0.75
69 1-(1-indanyl)- and 1-(1-tetralyl)imidazole-5-carboxylate esters, a novel type of antifungal agents. J Med Chem 1967 0.75
70 Monoclonal antibody-gold silver staining dot assay for the detection of antigenaemia in candidosis. Mycoses 1992 0.75
71 Ketoconazole (R 41 400) in the treatment of dermatophyte infections: a clinical, mycological, and morphological study. Int J Dermatol 1981 0.75